Flygt, H., Söderlund, S., Richter, J., Saußele, S., Koskenvesa, P., Stenke, L., . . . Olsson-Strömberg, U. (2024). Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial: Chronic myelogenous leukemia. Leukemia, 38(4), . https://doi.org/10.1038/s41375-024-02145-6
Chicago-Zitierstil (17. Ausg.)Flygt, Hjalmar, et al. "Treatment-free Remission After a Second TKI Discontinuation Attempt in Patients with Chronic Myeloid Leukemia Re-treated with Dasatinib - Interim Results from the DAstop2 Trial: Chronic Myelogenous Leukemia." Leukemia 38, no. 4 (2024). https://doi.org/10.1038/s41375-024-02145-6.
MLA-Zitierstil (9. Ausg.)Flygt, Hjalmar, et al. "Treatment-free Remission After a Second TKI Discontinuation Attempt in Patients with Chronic Myeloid Leukemia Re-treated with Dasatinib - Interim Results from the DAstop2 Trial: Chronic Myelogenous Leukemia." Leukemia, vol. 38, no. 4, 2024, https://doi.org/10.1038/s41375-024-02145-6.